ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

PRLD Prelude Therapeutics Inc

3.89
-0.01 (-0.26%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 32,316
Bid Price 1.60
Ask Price 5.79
News -
Day High 3.9079

Low
1.66

52 Week Range

High
5.83

Day Low 3.66
Share Name Share Symbol Market Stock Type
Prelude Therapeutics Inc PRLD NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.01 -0.26% 3.89 19:00:00
Open Price Low Price High Price Close Price Previous Close
3.84 3.66 3.9079 3.89 3.90
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
536 32,316 US$ 3.80 US$ 122,870 - 1.66 - 5.83
Last Trade Type Quantity Price Currency
15:02:32 priorref 1,112 US$ 3.90 USD

Prelude Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
213.64M 54.92M - 0 -121.83M -2.22 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Prelude Therapeutics News

Date Time Source News Article
6/12/202405:55Edgar (US Regulatory)Form 8-K - Current report
6/10/202423:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
6/03/202406:01GlobeNewswire Inc.Prelude Therapeutics to Participate in Upcoming Healthcare..
5/30/202415:29Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
5/16/202415:09Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]
5/16/202415:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
5/09/202406:01GlobeNewswire Inc.Prelude Therapeutics to Participate in Citizens JMP Life..
5/07/202406:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/07/202406:12Edgar (US Regulatory)Form 8-K - Current report
5/07/202406:01GlobeNewswire Inc.Prelude Therapeutics Reports First Quarter 2024 Financial..
5/06/202415:24Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of..
4/09/202415:35GlobeNewswire Inc.Prelude Highlights Continued Strength of Discovery Engine at..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PRLD Message Board. Create One! See More Posts on PRLD Message Board See More Message Board Posts

Historical PRLD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.794.443.593.9743,2120.102.64%
1 Month4.294.443.323.8444,077-0.40-9.32%
3 Months4.835.833.324.1441,407-0.94-19.46%
6 Months3.735.832.623.9965,7890.164.29%
1 Year5.595.831.663.49116,418-1.70-30.41%
3 Years31.2043.54991.6612.36182,296-27.31-87.53%
5 Years25.7695.3751.6620.69187,383-21.87-84.90%

Prelude Therapeutics Description

Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.

Your Recent History

Delayed Upgrade Clock